av/marksans-pharma--big.svg

COM:MARKSANSPHARMA

Marksans Pharma

  • Stock

INR

Last Close

308.65

25/11 09:40

Market Cap

87.17B

Beta: -

Volume Today

1.20M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
average inventory
901.40M
-
1.16B
29.07%
1.49B
28.02%
1.79B
20.13%
2.04B
14.06%
2.56B
25.27%
2.68B
4.64%
3.23B
20.76%
4.14B
28.26%
4.55B
9.70%
5.51B
21.28%
average payables
696.22M
-
951.01M
36.60%
1.13B
18.82%
1.40B
24.23%
1.15B
18.34%
867.75M
24.30%
1.05B
21.33%
1.37B
29.73%
1.84B
34.99%
2.15B
16.80%
2.49B
15.83%
average receivables
921.99M
-
2.14B
132.30%
2.60B
21.55%
3.44B
32.19%
4.15B
20.64%
2.25B
45.91%
book value per share
3.69
-
9.28
151.43%
11.10
19.63%
10.86
2.14%
11.50
5.91%
13.25
15.21%
15.54
17.24%
21.66
39.38%
29.37
35.62%
42.16
43.54%
46.01
9.14%
capex per share
-0.89
-
-3.22
261.64%
-0.68
78.96%
-0.95
40.31%
-0.32
66.23%
-1.46
353.55%
-1.13
22.14%
-1.13
0.20%
-1.30
14.47%
4.61
455.55%
capex to depreciation
-2.26
-
-4.69
107.44%
-0.92
80.33%
-1.45
57.33%
-0.58
60.26%
-2.24
287.93%
-1.28
42.58%
-1.03
19.43%
-1.03
0.04%
2.81
371.87%
capex to operating cash flow
-0.24
-
-4.28
1,714.21%
-3.14
26.71%
-0.66
78.94%
-0.48
27.38%
-0.28
40.82%
-0.26
8.55%
-0.47
79.71%
-0.23
51.60%
0.91
501.24%
capex to revenue
-0.05
-
-0.15
222.52%
-0.04
75.50%
-0.04
17.94%
-0.01
68.79%
-0.05
296.52%
-0.03
35.74%
-0.03
7.74%
-0.03
7.49%
0.10
431.23%
cash per share
1.22
-
4.53
271.48%
0.86
80.95%
0.61
28.72%
0.97
57.84%
0.80
17.28%
2.28
183.43%
5.16
126.70%
8.47
64.23%
17.37
105.12%
15.45
11.10%
days of inventory on hand
101.77
-
106.61
4.76%
120.16
12.71%
146.99
22.33%
145.23
1.19%
206.83
42.41%
155.32
24.91%
238.57
53.60%
207.11
13.19%
192.03
7.28%
206.12
7.34%
days payables outstanding
82.52
-
87.69
6.27%
85.20
2.84%
125.10
46.83%
44.93
64.09%
74.81
66.51%
67.11
10.29%
99.52
48.29%
97.63
1.90%
91.35
6.43%
89.49
2.04%
days sales outstanding
68.17
-
78.85
15.66%
73.81
6.38%
101.49
37.50%
82.53
18.69%
75.97
7.95%
debt to assets
0.26
-
0.12
52.44%
0.12
0.72%
0.15
19.02%
0.16
10.93%
0.12
22.93%
0.03
73.49%
0.03
16.02%
0.07
143.27%
0.06
16.90%
0.01
80.67%
debt to equity
0.88
-
0.22
75.45%
0.19
10.01%
0.25
26.71%
0.25
1.52%
0.18
26.26%
0.05
74.77%
0.04
17.48%
0.09
139.52%
0.07
23.54%
0.01
80.00%
dividend yield
0.01
-
0.00
75.69%
0.01
244.43%
0.01
20.56%
0.00
76.35%
0.00
135.00%
0.05
1,139.38%
0.00
96.14%
0.01
183.84%
0.00
38.58%
0.00
9.37%
earnings yield
0.08
-
0.04
44.70%
0.04
4.05%
0.00
88.09%
0.02
382.73%
0.08
218.06%
0.21
180.26%
0.12
45.03%
0.10
14.02%
0.09
9.23%
0.04
51.90%
enterprise value
9.99B
-
24.31B
143.23%
19.48B
19.84%
20.14B
3.40%
14.62B
27.44%
11.30B
22.73%
5.05B
55.25%
18.69B
269.80%
16.27B
12.96%
26.54B
63.16%
70.03B
163.83%
enterprise value over ebitda
8.48
-
13.45
58.56%
13.79
2.55%
40.65
194.72%
17.58
56.74%
8.50
51.63%
2.68
68.52%
5.27
97.03%
5.52
4.72%
6.66
20.57%
13.76
106.62%
ev to operating cash flow
15.41
-
15.73
2.07%
63.26
302.12%
227.82
260.15%
24.81
89.11%
41.23
66.20%
2.41
94.16%
10.46
334.35%
16.39
56.73%
11.18
31.78%
30.40
171.85%
ev to sales
1.59
-
3.05
92.34%
2.18
28.51%
2.63
20.40%
1.60
39.01%
1.14
28.57%
0.45
60.88%
1.37
205.20%
1.10
19.54%
1.43
30.39%
3.22
124.42%
free cash flow per share
1.68
-
2.88
71.38%
-2.47
185.62%
-0.46
81.29%
0.49
205.71%
0.35
28.70%
3.67
954.97%
3.23
11.97%
1.29
60.00%
4.44
243.37%
0.48
89.28%
free cash flow yield
0.07
-
0.05
33.83%
-0.05
214.47%
-0.01
81.63%
0.01
247.46%
0.01
7.14%
0.26
1,869.52%
0.06
75.50%
0.03
56.09%
0.06
121.92%
0.00
95.23%
graham net net
-6.31
-
-0.91
85.52%
-3.43
275.24%
-4.43
29.23%
-2.44
44.85%
1.63
166.80%
3.65
123.60%
7.28
99.54%
11.01
51.21%
20.54
86.66%
16.63
19.03%
graham number
12.45
-
23.62
89.76%
21.89
7.34%
7.54
65.56%
14.43
91.44%
24.21
67.73%
32.12
32.67%
53.29
65.94%
54.92
3.06%
77.98
41.98%
84.22
8.00%
income quality
0.90
-
1.41
56.64%
0.29
79.59%
0.57
97.53%
1.18
107.79%
0.26
77.80%
1.34
408.59%
0.59
55.72%
0.40
32.21%
0.70
75.33%
0.73
4.46%
intangibles to total assets
0.15
-
0.09
37.01%
0.15
55.39%
0.14
6.78%
0.13
6.36%
0.09
30.12%
0.09
3.37%
0.05
40.78%
0.05
1.01%
0.05
7.63%
0.04
22.05%
interest coverage
17.92
-
16.98
5.28%
3.92
76.91%
7.95
102.68%
18.45
132.24%
32.63
76.81%
91.78
181.29%
46.34
49.50%
37.99
18.02%
69.55
83.07%
interest debt per share
3.25
-
2.22
31.75%
2.32
4.28%
2.78
19.94%
3.04
9.49%
2.59
14.72%
0.85
67.38%
0.92
8.52%
2.84
209.20%
3.19
12.43%
0.89
72.14%
inventory turnover
3.59
-
3.42
4.54%
3.04
11.27%
2.48
18.25%
2.51
1.21%
1.76
29.78%
2.35
33.17%
1.53
34.90%
1.76
15.19%
1.90
7.85%
1.77
6.84%
invested capital
0.88
-
0.22
75.45%
0.19
10.01%
0.25
26.71%
0.25
1.52%
0.18
26.26%
0.05
74.77%
0.04
17.48%
0.09
139.52%
0.07
23.54%
22.70B
32,223,643,785,739.20%
market cap
9.21B
-
25.34B
175.13%
18.95B
25.20%
19.30B
1.84%
13.83B
28.31%
10.62B
23.22%
5.69B
46.44%
20.45B
259.35%
18.62B
8.91%
29.14B
56.47%
71.63B
145.80%
net current asset value
16.68M
-
2.21B
13,159.41%
1.81B
18.28%
1.82B
0.91%
2.00B
9.79%
2.80B
40.06%
3.42B
22.12%
5.79B
69.17%
7.84B
35.34%
12.50B
59.42%
12.67B
1.40%
net debt to ebitda
0.67
-
-0.57
185.70%
0.38
166.00%
1.71
353.17%
0.94
44.83%
0.51
46.11%
-0.34
166.27%
-0.49
47.13%
-0.80
61.64%
-0.65
18.57%
-0.31
51.95%
net income per share
1.87
-
2.67
43.21%
1.92
28.23%
0.23
87.88%
0.80
246.05%
1.97
144.19%
2.95
50.12%
5.83
97.55%
4.56
21.68%
6.41
40.44%
6.92
7.96%
operating cash flow per share
1.68
-
3.77
124.33%
0.75
80.07%
0.22
71.29%
1.44
566.34%
0.67
53.50%
5.13
666.36%
4.37
14.86%
2.42
44.47%
5.74
136.53%
5.08
11.39%
payables turnover
4.42
-
4.16
5.90%
4.28
2.92%
2.92
31.89%
8.12
178.44%
4.88
39.94%
5.44
11.47%
3.67
32.56%
3.74
1.93%
4.00
6.87%
4.08
2.08%
receivables turnover
5.35
-
4.63
13.54%
4.94
6.82%
3.60
27.27%
4.42
22.98%
4.80
8.63%
research and ddevelopement to revenue
0.01
-
return on tangible assets
0.17
-
0.18
3.64%
0.13
28.76%
0.01
88.50%
0.05
253.48%
0.11
112.19%
0.15
34.98%
0.21
38.51%
0.12
41.38%
0.13
5.88%
0.12
4.51%
revenue per share
16.35
-
19.46
19.04%
21.82
12.13%
18.74
14.12%
22.30
18.97%
24.12
8.18%
27.59
14.38%
33.43
21.17%
36.16
8.17%
44.75
23.74%
48.03
7.34%
roe
0.51
-
0.29
43.04%
0.17
40.01%
0.02
87.61%
0.07
226.74%
0.15
111.96%
0.19
28.04%
0.27
41.73%
0.16
42.25%
0.15
2.16%
0.15
0.08%
roic
0.28
-
0.24
11.93%
0.15
37.11%
0.02
85.78%
0.06
190.65%
0.13
108.24%
0.18
40.40%
0.27
45.74%
0.14
49.20%
0.14
2.50%
0.28
97.91%
sales general and administrative to revenue
0.02
-
0.03
4.23%
0.02
9.70%
0.02
3.98%
0.02
32.31%
0.02
9.71%
0.02
4.00%
0.01
-
shareholders equity per share
3.69
-
9.28
151.43%
11.10
19.63%
10.86
2.14%
11.50
5.91%
13.25
15.21%
15.54
17.24%
21.66
39.38%
29.37
35.62%
42.16
43.54%
45.55
8.04%
stock based compensation to revenue
tangible asset value
756.51M
-
3.24B
328.73%
3.57B
10.12%
3.48B
2.47%
3.87B
11.21%
4.81B
24.17%
5.66B
17.76%
8.38B
47.99%
11.34B
35.31%
16.56B
45.96%
19.82B
19.68%
tangible book value per share
3.86
-
9.48
145.34%
11.30
19.29%
11.01
2.56%
9.46
14.07%
11.75
24.17%
13.84
17.76%
20.48
47.99%
27.71
35.31%
40.00
44.34%
43.71
9.28%
working capital
238.26M
-
2.23B
834.27%
1.81B
18.82%
1.82B
0.91%
2.16B
18.37%
2.99B
38.43%
3.71B
23.99%
6.04B
62.98%
8.45B
39.93%
13.34B
57.91%
14.73B
10.37%

All numbers in INR (except ratios and percentages)